Kalaris Therapeutics, Inc. (KLRS)

NASDAQ: KLRS · Real-Time Price · USD

4.000

-0.080 (-1.96%)

At close: Sep 2, 2025, 4:00 PM

4.100

+0.100 (2.50%)

After-hours: Sep 2, 2025, 5:33 PM EDT

Kalaris Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	88.43	1.64	3.17	3.06
Cash & Short-Term Investments	88.43	1.64	3.17	3.06
Cash Growth	2690.34%	-48.28%	3.60%	-
Prepaid Expenses	3.23	0.97	0.16	0.84
Total Current Assets	91.65	2.61	3.33	3.9
Long-Term Deferred Charges	-	3.15	-	-
Other Long-Term Assets	1.19	0.41	-	-
Total Assets	92.84	6.16	3.33	3.9
Accounts Payable	3.68	1.56	2.36	2.75
Accrued Expenses	3.83	2.13	1	2.52
Short-Term Debt	-	19.91	-	-
Other Current Liabilities	0.14	1.11	0.58	0.42
Total Current Liabilities	7.65	24.7	3.94	5.69
Long-Term Debt	-	-	-	3.25
Other Long-Term Liabilities	32.08	32.08	-	0.26
Total Liabilities	39.73	56.78	3.94	9.21
Additional Paid-In Capital	191.22	19.95	2.38	2.42
Retained Earnings	-138.11	-116.56	-47.39	-32.7
Total Common Equity	53.12	-96.62	-45.02	-30.27
Shareholders' Equity	53.12	-50.62	-0.61	-5.31
Total Liabilities & Equity	92.84	6.16	3.33	3.9
Total Debt	-	19.91	-	3.25
Net Cash (Debt)	88.43	-18.27	3.17	-0.19
Net Cash Per Share	7.57	-2.76	0.52	-0.04
Filing Date Shares Outstanding	18.7	18.7	6.76	4.44
Total Common Shares Outstanding	18.7	6.73	6.76	4.44
Working Capital	84	-22.1	-0.61	-1.79
Book Value Per Share	2.84	-14.36	-6.66	-6.81
Tangible Book Value	53.12	-96.62	-45.02	-30.27
Tangible Book Value Per Share	2.84	-14.36	-6.66	-6.81

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q